Alere BinaxNOW S. pneumoniae and Legionella brochure

Product catalog summary

Overview: The document discusses the Alere BinaxNOW® rapid urine antigen tests for detecting Streptococcus pneumoniae and Legionella, which provide results in 15 minutes, allowing for timely and accurate treatment of Community Acquired Pneumonia (CAP).

Specifications: The tests are unaffected by prior antibiotic treatments and are designed for point-of-care use in emergency departments and hospital laboratories. They offer high sensitivity and specificity compared to traditional methods.

Community Acquired Pneumonia (CAP): CAP is a significant health issue, especially in the elderly and those with comorbidities, leading to high morbidity and mortality rates. Guidelines from IDSA/ATS and BTS recommend urine antigen testing for accurate diagnosis and management.

Antimicrobial Stewardship: Accurate diagnosis is crucial to avoid inappropriate antibiotic use, reduce healthcare costs, and combat antimicrobial resistance.

Testing Procedure: The test involves dipping a swab into a urine specimen, placing it into the device, adding a reagent, and waiting 15 minutes for results. A positive result shows two lines, while a negative result shows one line.

Performance: The Alere BinaxNOW® tests show high sensitivity and specificity for both S. pneumoniae and Legionella antigens, outperforming traditional blood and sputum cultures in terms of speed and accuracy.

Ordering Information: The document provides order numbers for different test kit sizes and control swabs, along with contact information for Alere International Limited.

Catalog excerpts

Alere BinaxNOW S. pneumoniae and Legionella brochure-1

Pneumonia - Know the Cause Now Mere BinaxNOW rapid urine antigen tests Streptococcus pneumoniae

Open the catalog to page 1

Alere BinaxNOW S. pneumoniae and Legionella brochure-2

Alere BinaxNOW S. pneumoniae and Legionella ® Community Acquired Pneumonia (CAP) Alere BinaxNOW S. pneumoniae and Legionella CAP is associated with considerable morbidity and mortality, particularly in elderly patients and those with significant comorbidities. The clinical and economic burden of CAP is high worldwide and long term prognosis is worse for patients with pneumococcal pneumonia. Alere BinaxNOW urine antigen tests empower healthcare professionals to quickly and accurately identify two of the most common causes of CAP: Streptococcus pneumoniae and Legionella pneumophila serogroup 1....

Open the catalog to page 2

Alere BinaxNOW S. pneumoniae and Legionella brochure-3

Performance compared to traditional methods Methodology Component Detected Sample Type Turnaround Time Alere BinaxNOW S. pneumoniae Blood Culture Sputum Culture Sputum Gram Stain a) Retrospective Study data. Blood culture used as reference. b) Numbers reflect percent of pneumococcal pneumonia patient population estimated to be bacteremic. Component Detected Sample Type Turnaround Time Alere BinaxNOW Legionella Sputum Culture Ordering Information: Alere BinaxNOW S. pneumoniae Test 12 Test Kit Order No. 710-012 22 Test Kit Order No. 710-000 Control swabs – 5 positive & 5 negative swabs Order No....

Open the catalog to page 3